查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451545

2024-2032 年按治療類型、藥物類別、配銷通路和地區分類的失眠市場報告

Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年全球失眠市場規模達52億美元。展望未來， IMARC Group預計到2032年市場規模將達到66億美元，2024-2032年複合年成長率（CAGR）為2.69%。

失眠是一種睡眠障礙，會降低能量水平並影響個人的情緒、健康、工作表現和整體生活品質。其常見原因包括壓力、長途旅行、繁忙的工作日程、不良的睡眠習慣、暴飲暴食以及過量攝取尼古丁、咖啡因和酒精。它也可能與心理健康障礙有關，例如創傷後壓力症候群，以及使用治療氣喘或血壓的抗憂鬱藥物以及緩解疼痛、過敏和感冒的非處方藥 (OTC) 等藥物。其治療方案，例如認知行為療法（CBT）、非處方睡眠輔助藥物以及右佐匹克隆和雷美替胺等處方藥，目前在全球範圍內可用。

失眠市場趨勢：

冠狀病毒病 (COVID-19) 大流行為生活帶來了前所未有的變化，包括社會隔離以及無數的工作挑戰和家庭義務。這是一個重大的壓力事件，影響了數百萬人的睡眠模式並加強了市場的成長。此外，慢性疼痛、癌症、糖尿病、心臟病、氣喘、胃食道逆流（GERD）、甲狀腺功能亢進、帕金森氏症和阿茲海默症等疾病通常與失眠有關。因此，患有這些疾病的人數不斷增加，推動了對失眠藥物的需求。除此之外，月經週期和更年期期間的荷爾蒙變化可能導致失眠的風險，這有助於市場成長。此外，由於睡眠模式、活動和健康的變化以及處方藥使用的增加會增加老年人失眠的機會，全球不斷成長的老年人口正在催化對失眠醫療的需求。此外，增加對測試新療法、干預措施和預防、檢測、治療和管理失眠的測試的投資預計將推動市場發展。

本報告回答的關鍵問題

  • 2023年全球失眠市場規模有多大？
  • 2024-2032年全球失眠市場的預期成長率是多少？
  • 推動全球失眠市場的關鍵因素是什麼？
  • COVID-19 對全球失眠市場有何影響？
  • 根據治療類型，全球失眠市場的詳細情形如何？
  • 根據藥物類別，全球失眠市場的細分如何？
  • 全球失眠市場的重點地區有哪些？
  • 誰是全球失眠市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球失眠市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依治療類型

  • 非藥物治療
    • 市場走向
    • 關鍵環節
      • 催眠療法
      • 認知行為療法
      • 醫療設備
      • 其他
    • 市場預測
  • 藥物治療
    • 市場走向
    • 關鍵環節
      • 處方助眠藥
      • 非處方助眠藥
    • 市場預測

第 7 章：市場區隔：依藥物類別

  • 抗憂鬱藥
    • 市場走向
    • 市場預測
  • 褪黑素拮抗劑
    • 市場走向
    • 市場預測
  • 苯二氮平類
    • 市場走向
    • 市場預測
  • 非苯二氮平類藥物
    • 市場走向
    • 市場預測
  • 食慾素拮抗劑
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • Aurobindo Pharma Limited
    • Biocodex
    • Eisai Co. Ltd.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co. Inc.
    • Neurim Pharmaceuticals Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
    • Takeda Pharmaceutical Company Limited
    • Vanda Pharmaceuticals Inc.
Product Code: SR112024A6148

The global insomnia market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 2.69% during 2024-2032.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global insomnia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapy type, drug class and distribution channel.

Breakup by Therapy Type:

Non-Pharmacological Therapy

Hypnotherapy

Cognitive Behavioral Therapy

Medical Devices

Others

Pharmacological Therapy

Prescription Sleep Aids

Over-The-Counter Sleep Aids

Breakup by Drug Class:

Antidepressants

Melatonin Antagonist

Benzodiazepines

Nonbenzodiazepines

Orexin Antagonist

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global insomnia market in 2023?
  • 2. What is the expected growth rate of the global insomnia market during 2024-2032?
  • 3. What are the key factors driving the global insomnia market?
  • 4. What has been the impact of COVID-19 on the global insomnia market?
  • 5. What is the breakup of the global insomnia market based on the therapy type?
  • 6. What is the breakup of the global insomnia market based on the drug class?
  • 7. What are the key regions in the global insomnia market?
  • 8. Who are the key players/companies in the global insomnia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Insomnia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapy Type

  • 6.1 Non-Pharmacological Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Hypnotherapy
      • 6.1.2.2 Cognitive Behavioral Therapy
      • 6.1.2.3 Medical Devices
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Pharmacological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Prescription Sleep Aids
      • 6.2.2.2 Over-The-Counter Sleep Aids
    • 6.2.3 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Antidepressants
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Melatonin Antagonist
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Benzodiazepines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Nonbenzodiazepines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Orexin Antagonist
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Pharmacies
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aurobindo Pharma Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Biocodex
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eisai Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Mallinckrodt Pharmaceuticals
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Neurim Pharmaceuticals Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vanda Pharmaceuticals Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Insomnia Market: Major Drivers and Challenges
  • Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2023
  • Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2023
  • Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Insomnia Industry: SWOT Analysis
  • Figure 82: Global: Insomnia Industry: Value Chain Analysis
  • Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Insomnia Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
  • Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Insomnia Market: Competitive Structure
  • Table 7: Global: Insomnia Market: Key Players